Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 127

Results For "medicines"

1416 News Found

Fujifilm launches awareness campaign on detecting TB
Public Health | November 28, 2021

Fujifilm launches awareness campaign on detecting TB

The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.


Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets


Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate
Biotech | November 24, 2021

Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate

Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales


AstraZeneca opens Discovery Centre in Cambridge
Biotech | November 23, 2021

AstraZeneca opens Discovery Centre in Cambridge

State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem


European Commission approves Roche’s Gavreto
Drug Approval | November 22, 2021

European Commission approves Roche’s Gavreto

Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC


Flipkart acquires SastaSundar, an online pharmacy and healthcare platform
Startup | November 20, 2021

Flipkart acquires SastaSundar, an online pharmacy and healthcare platform

Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+


Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
Biotech | November 20, 2021

Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn

Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease


Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards
Policy | November 16, 2021

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards


Biocon Biologics partners with RSSDI to expand insulin access
Public Health | November 16, 2021

Biocon Biologics partners with RSSDI to expand insulin access

BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children


European Commission approves Celltrion’s Covid-19 medicine
Drug Approval | November 15, 2021

European Commission approves Celltrion’s Covid-19 medicine

The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week